BiotechTube
Home/Kivu Bioscience/Brunilda Shtylla
BS

Brunilda Shtylla

Chief Business Officer

Kivu Bioscience

Therapeutic Areas

Oncology

Kivu Bioscience Pipeline

DrugIndicationPhase
KIVU-107Solid tumorsIND-Enabling
KIVU-305Solid tumorsIND-Enabling
KIVU-495Solid tumorsIND-Enabling
KIVU-202Solid tumorsDevelopment Candidate

Leadership Team at Kivu Bioscience

MT
Mohit Trikha, PhD
President & Chief Operating Officer, Board Member
SR
Sophia Randolph, MD, PhD
Chief Medical Officer
DO
Daniel O’Connell, MD, PhD
Board Chair, Partner at Novo Holdings
View full Kivu Bioscience profile